Medicines and Healthcare products Regulatory Agency
gov.uk Imported from official source
UK medicines and medical devices regulator; recalls and safety alerts.
Publications 151
-
Transparency data: Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2026-27
HRA transactions over £500 made using the government procurement card (GPC).
Alert Safety -
Guidance: London Region I MHRA Regulatory Sandbox: call for expressions of interest
Expressions of interest are invited from AI-enabled medical device manufacturers and NHS provider organisations interested in participating in the London Region I MHRA Regulatory Sandbox.
Alert AI -
Consultation on the regulation of Gene therapy medicinal products
We are seeking views on proposed updates to the definition of Gene therapy medicinal products to better reflect advances in science and manufacturing.
Alert Safety -
MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.
Alert Safety -
Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices
This consultation invites views on proposals for recognising CE marked medical devices in Great Britain.
Alert Safety -
Guidance: The Centres of Excellence for Regulatory Science and Innovation programme (CERSIs)
A national programme to help drive advancements in healthcare, to ensure patients benefit from innovation and new treatments sooner.
Alert Safety -
National assessment procedure for medicines
Guidance on the MHRA’s national assessment procedure for marketing authorisation applications.
Alert Safety -
Transparency data: MHRA Performance Data
Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline to complete a specific regulatory function.
Alert Safety -
Field Safety Notices: 27 to 31 January 2025
List of Field Safety Notices from 27 to 31 January 2025.
Alert Safety -
Guidance: Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is focused on getting the most transformative new medicines to patients in the UK health system more quickly.
Alert Safety -
Corporate report: MHRA-NICE Real-World Evidence Scientific Dialogue
A programme to help decision making across the lifecycle of products, benefitting both regulatory and health technology assessment (HTA) evaluations.
Alert Safety -
Pre-submission Advice & Support for Innovative Medicines
The Medicines and Healthcare products Regulatory Agency (MHRA) offer a pre-submission service before applying for medicines Marketing Authorisations and clinical variations innovative medicines.
Alert Safety -
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Alert Safety -
Guidance: The Innovative Devices Access Pathway (IDAP)
The Innovative Devices Access Pathway (IDAP) pilot is designed to accelerate the development of innovative medical devices that meet an unmet clinical need in the NHS and support their integration ...
Alert Safety -
Guidance: International Recognition Procedure
How to use the procedure for medicines licensing applications.
Alert Safety -
Decision: Human medicines: register of electronic export certificates
Department of Health and Social Care and MHRA register of electronic export certificates (human).
Alert Safety -
Guidance: Good machine learning practice for medical device development
10 guiding principles that can inform the development of good machine learning practice (GMLP).
Alert AI -
Guidance: COVID-19 test validation approved products
Find out which COVID-19 test products have been approved.
Alert Safety -
COVID-19 test approval: how to apply
How manufacturers or distributors of Coronavirus (COVID-19) test devices can apply for approval of their tests to be placed on the UK market.
Alert Safety -
Decision: Orphan registered medicinal products
A list of authorised orphan medicinal products registered by the UK licensing authority.
Alert Safety -
Register medical devices to place on the market
How to register your medical devices with the MHRA for the markets in Great Britain and Northern Ireland.
Alert Safety -
Renewing marketing authorisations for medicines
How to renew marketing authorisations for products granted through different routes and at different times.
Alert Safety -
Guidance: Guidance on pharmacovigilance procedures
This guidance summarises our approach to pharmacovigilance
Alert Safety -
Access, new active substance and biosimilar work sharing initiatives
Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.
Alert Safety -
Decision: Medical devices given exceptional use authorisations
List of manufacturers and their medical devices granted an exemption by MHRA. The list also includes manufacturers whose exemption expired or was cancelled.
Alert Safety -
Opportunities for patients and the public to be involved in the work of the MHRA
How we engage and involve patients and the public in our regulatory decision-making.
Alert Safety -
Find product information about medicines
How to get information including patient information leaflets (PILs), details on how the medicine can be used (SPCs) and scientific reports (PARs).
Alert Safety -
Guidance: Medicines that you cannot export from the UK or hoard
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
Alert Safety -
Safety Public Assessment Reports
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Alert Safety -
Decision: Human and veterinary medicines: register of licensed manufacturing sites
The MHRA register of licensed manufacturing sites: manufacturer specials - human (MS) and manufacturer specials authorisation - veterinary (MANSA) only.
Alert Safety -
Decision: Human medicines: register of licensed wholesale distribution sites
Department of Health and Social Care and MHRA register of licensed wholesale distribution sites (human).
Alert Safety -
Official Statistics: Quarterly reports on the import of unlicensed medicines
Details and statistics on the import of unlicensed medicines from March 2014 onwards.
Alert Safety -
Notice: Medicines: terminated and cancelled manufacturing and wholesale dealer licences
UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.
Alert Safety -
Decision: Medicines: new manufacturing and wholesale dealer licences
List of sites granted a manufacturer or wholesale dealer licence.
Alert Safety -
Advanced therapy medicinal products: regulation and licensing in UK
How to get a marketing authorisation (MA) for an advanced therapy medicinal product (ATMP) so it can be sold and/or supplied in the United Kingdom.
Alert Safety -
Guidance: Herbal medicines granted a traditional herbal registration (THR)
A list of herbal medicines currently holding a traditional herbal registration (THR) granted by the Medicines and Healthcare products Regulatory Agency (MHRA).
Alert Safety -
Guidance: Antidepressants: use and safety
Guidance on the use and side effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs), their safety, use in pregnancy and the risk of s...
Alert Safety -
Clinical investigations for medical devices
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Alert Safety -
Good laboratory practice (GLP) for safety tests on chemicals
Keep up to date with the latest information from the UK GLP monitoring authority.
Alert Safety -
Apply for a licence to market a medicine in the UK
An overview of the process to get a marketing authorisation (MA), including submitting, fast-tracking an application, naming your medicine and paying fees.
Alert Safety -
Medicines: apply for a variation to your marketing authorisation
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Alert Safety -
Clinical trials for medicines: Good clinical practice inspections
Information relating to good clinical practice (GCP) inspections.
Alert Safety -
Medicines: reclassify your product
Pharmacy (P), prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Alert Safety -
Notice: Register of brokers authorised to deal in human medicines
Current listing of UK brokers authorised to broker human medicines, including company name, registration and address.
Alert Safety -
Decision: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
Alert Safety -
Send and receive information on adverse drug reactions (ADRs)
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Alert Safety -
Guidance: Magnetic resonance imaging equipment in clinical use: safety guidelines
Relevant safety information for users of magnetic resonance imaging (MRI) equipment in clinical use.
Alert Safety